Pulmonary heart disease, also known as cor pulmonale, is a condition characterized by the enlargement and dysfunction of the right side of the heart. This condition is typically a consequence of prolonged high blood pressure in the pulmonary arteries, which are responsible for carrying blood from the heart to the lungs. Chronic respiratory conditions such as chronic obstructive pulmonary disease (COPD), pulmonary hypertension, and interstitial lung diseases are common contributors to the development of pulmonary heart disease. The increased resistance in the pulmonary circulation forces the right side of the heart to pump harder, leading to its enlargement and potential failure over time. Indications may involve difficulty breathing, tiredness, and edema in the legs. Timely diagnosis and management of the underlying respiratory condition are crucial in addressing and preventing the progression of pulmonary heart disease.
Title : Surgical fetal stem cells implantation in heart failure patients long term results at 14 years
Federico Benetti, Benetti Foundation, Argentina
Title : Exploring new biomarkers of cardiomyopathy
Shuping Zhong, University of Southern California, United States
Title : The development of human relaxin-2 for heart failure with preserved ejection fraction, HFpEF
Thomas Bernd Dschietzig, Relaxera GmbH & Co. KG, Germany
Title : Cancer and cardiovascular diseases: Common pathogenesis mechanisms and risk factors
Mekhman N Mamedov, National Research Center for Preventive Medicine, Russian Federation
Title : Pulse field ablation for atrial fibrillation complications: What do we know yet
Narendra Kumar, HeartbeatsZ Academy, United Kingdom
Title : Lipoprotein (a): The hidden cardiovascular risk
Syed Raza, Awali Hospital, Bahrain